Telehealth Provider Data: Challenges and Solutions

Virtual-Only vs. Hybrid: The First Segmentation That Matters

Not all telehealth providers are the same. The market splits into three distinct segments, each with different buying behaviors and data needs.

Virtual-Only Providers

These are companies and individual practitioners who deliver care exclusively through video, phone, or asynchronous messaging. Companies like Cerebral, Done, Talkiatry, and hundreds of smaller operations fall here. Individual providers who went fully virtual during the pandemic and never returned to in-person practice are also in this bucket.

Data challenges with virtual-only providers:

• No meaningful physical address. Their NPI registration might list a home address, a UPS Store mailbox, or a registered agent's office. None of these are useful for territory mapping.
• Company vs. Individual NPI confusion. Large telehealth companies often have an organizational NPI (Type 2) plus individual NPIs (Type 1) for each provider. If you're targeting the company, you want the Type 2 entity. If you're targeting individual prescribers, you want Type 1 records linked to that company.
• Rapid headcount changes. Virtual-only companies scale provider headcount up and down quickly. A telehealth startup might go from 50 to 200 providers in a quarter, then back to 100 after a funding round falls through. Your data ages faster here than in any other healthcare segment.

Hybrid Providers

These are traditional brick-and-mortar practices that added telehealth as a service line. A primary care practice that sees patients in-office 3 days a week and offers telehealth visits 2 days. A behavioral health group that does initial assessments in-person and follow-ups via video. This is the largest segment by provider count.

The data challenge with hybrid providers is identifying which ones actively use telehealth vs. Which ones technically "offer" it but do fewer than 5 virtual visits per month. Many practices added telehealth capability during COVID, collected the FQHC or telehealth modifier reimbursements, and then quietly stopped once in-person volumes recovered. If you're selling telehealth-specific software, you need volume indicators, not just capability flags.

Telehealth Platforms

Companies like Teladoc, Amwell, MDLive, and their competitors operate as platforms that employ or contract with thousands of providers. These are enterprise sales targets, not individual provider outreach. Your data needs for this segment are completely different: company firmographics, decision-maker contacts (Chief Medical Officer, VP of Clinical Operations, Head of Provider Network), and contract details.

Check our mental health provider data guide for deep coverage of the behavioral health telehealth segment, which accounts for the largest share of virtual visits.

DEA Telehealth Prescribing Rules: Why They Matter for Your Data

If you're selling to telehealth prescribers, the DEA's evolving telehealth prescribing rules are critical context. During the COVID public health emergency, the DEA allowed providers to prescribe controlled substances via telehealth without an in-person visit. As that flexibility winds down, the rules are getting more complex.

As of early 2026, the DEA has proposed rules that would require an initial in-person visit for Schedule II-V controlled substance prescriptions initiated via telehealth, with some exceptions. This directly affects:

• Telepsychiatry providers prescribing stimulants (ADHD medications like Adderall, Vyvanse) and benzodiazepines
• Pain management telehealth providers prescribing opioids and muscle relaxants
• Telehealth companies built specifically around controlled substance prescribing (some of which have already shut down or pivoted)

For data purposes, you need to distinguish between telehealth prescribers who handle controlled substances and those who don't. A teledermatology company prescribing topical retinoids isn't affected by DEA rule changes. A telepsychiatry company prescribing Adderall is directly in the crosshairs. The DEA registration status and Schedule classifications in your provider data become critical filtering fields.

The Impact on Your Target List

DEA rule changes will cause market consolidation. Some virtual-only prescribers of controlled substances will need to add in-person capabilities or partner with brick-and-mortar practices. This means your data needs to track these transitions. A provider who was virtual-only in 2025 might be hybrid by mid-2026. If your database still shows them as virtual-only, your reps are working with outdated intelligence.

Finding Telehealth Providers in Your Data

Here's the step-by-step process for building a telehealth provider database.

Step 1: NPI Registry Signals

The NPI registry doesn't have a "telehealth" flag. But there are signals. Look for: practice addresses that are clearly residential or virtual office spaces, providers with multiple practice location addresses in different states, and taxonomy codes associated with high telehealth adoption (psychiatry, psychology, primary care, dermatology).

Step 2: State License Cross-Referencing

Providers with licenses in 5+ states who aren't part of a large health system are likely doing telehealth. Cross-reference NPI data with state medical board records to build a multi-state license profile for each provider. The Interstate Medical Licensure Compact database is a useful starting point.

Step 3: Telehealth Platform Identification

Identify providers affiliated with known telehealth platforms. Scrape organizational NPI records for major telehealth companies, then link individual providers to those organizations. This captures employed and contracted telehealth providers who might not be identifiable from NPI data alone.

Step 4: Website and Marketing Signal Analysis

Practices that offer telehealth almost always market it on their websites. Look for: "telehealth," "virtual visits," "online appointments," video platform integration pages, and state-specific "we see patients in..." language. This is particularly useful for identifying hybrid providers who added telehealth as a service line.

Step 5: Claims-Based Identification

If you have access to claims data, telehealth visits are identifiable through place-of-service code 02 (Telehealth Provided Other than in Patient's Home) and modifier 95 (Synchronous Telemedicine Service). Providers with significant volume on these codes are confirmed telehealth practitioners.

Telehealth Market Sizing: Getting the Numbers Right

Market sizing for telehealth is tricky because the definition keeps shifting. Here's a framework that works:

1. Virtual-only companies and their employed/contracted providers. Start with the known telehealth companies and count their provider networks. This is the most clearly defined segment. Estimated at 50,000-80,000 providers nationally, though many work part-time on these platforms.
2. Hybrid practices with active telehealth service lines. Estimated at 150,000-200,000 practices that conducted at least 10 telehealth visits in the past quarter. This number is softer because it depends on how you define "active."
3. Individual providers with telehealth capability but low volume. Hundreds of thousands of providers technically have telehealth capabilities through their EHR system. Most don't use it regularly. Including them inflates your TAM without improving your pipeline.

For most sales motions, segments 1 and 2 are your real TAM. Segment 3 is aspirational. Your data should clearly distinguish between them so you can focus outreach on providers who are doing telehealth, not providers who once set up a Zoom account. Check out our 2026 provider data trends article for broader context on how verification frequency affects data quality across all segments.